Showing 1 - 10 of 238
Persistent link: https://www.econbiz.de/10010861406
Persistent link: https://www.econbiz.de/10010707914
This paper studies the relationship between the diffusion of innovative procedures for the treatment of heart attack and distributions of the cost and length of hospital stays. Using a sample of 5,681 stays observed in French public hospitals, we use microsimulation techniques to highlight...
Persistent link: https://www.econbiz.de/10010708126
Persistent link: https://www.econbiz.de/10010708719
Introduction : Benefit-risk of different anti-rabies post-exposure prophylaxis (PEP) strategies after scratches or bites from dogs with unknown rabies status is unknown in very low rabies risk settings. Design and setting : A cost-effectiveness analysis in metropolitan France using a...
Persistent link: https://www.econbiz.de/10011212046
Objectives To assess the efficacy and the cost of a French team work experiment between nurses and GPs for managing type 2 diabetes patients. Methods Based on a case control study design we compare the evolution of process (standard follow-up procedures) and final (glycemic control) outcomes,...
Persistent link: https://www.econbiz.de/10011265516
Persistent link: https://www.econbiz.de/10011265534
Background Patent expiries on leading biologics are creating new momentum in the market for biosimilars (copies of off-patent biologics), paving the way for their development. However, little is known about the factors influencing the competition between biosimilars and their reference products...
Persistent link: https://www.econbiz.de/10011228183
Background In 2009, a voluntary-based pay for performance scheme targeting general practitioners (GPs) was introduced in France through the ‘Contract for Improving Individual Practices’ (CAPI). Objective To study the impact of the CAPI on French GPs’ consultation length. Methods Univariate...
Persistent link: https://www.econbiz.de/10011228192
Objective: The objective of the study was to compute a cost-effectiveness ratio relating the economic cost of trandolapril to the number of effectiveness units (i.e. life-years) gained. Design and Setting: The trandolapril cardiac evaluation (TRACE) study was a prospective placebo-controlled...
Persistent link: https://www.econbiz.de/10010723167